Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,868 | -14,455 | -44,822 | -31,979 | -61,052 |
| Depreciation Amortization | 786 | 406 | 1,962 | 1,587 | 1,177 |
| Accounts receivable | N/A | 80 | 15,138 | 15,143 | 1,523 |
| Accounts payable and accrued liabilities | -2,063 | -1,826 | -2,076 | 2,433 | 5,643 |
| Other Working Capital | 2,172 | 1,414 | 491 | 3,833 | 6,055 |
| Other Operating Activity | 6,694 | 4,697 | -49,601 | -56,190 | -2,854 |
| Operating Cash Flow | $-17,279 | $-9,684 | $-78,908 | $-65,173 | $-49,508 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,866 | N/A | 8 | 8 | -1,992 |
| PPE Investments | -275 | -108 | -199 | -250 | -253 |
| Net Acquisitions | N/A | N/A | 62,908 | 62,908 | N/A |
| Investing Cash Flow | $-10,141 | $-108 | $62,717 | $62,666 | $-2,245 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,000 | -10,000 | -40,039 | -40,029 | -19 |
| Common Stock Issued | 17,972 | 14,899 | 1,337 | 301 | 163 |
| Other Financing Activity | -2,041 | -2,041 | 30,760 | 0 | 0 |
| Financing Cash Flow | $5,931 | $2,858 | $-7,942 | $-39,728 | $144 |
| Beginning Cash Position | 70,745 | 70,745 | 94,878 | 94,878 | 94,878 |
| End Cash Position | 49,256 | 63,811 | 70,745 | 52,643 | 43,269 |
| Net Cash Flow | $-21,489 | $-6,934 | $-24,133 | $-42,235 | $-51,609 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,279 | -9,684 | -78,908 | -65,173 | -49,508 |
| Capital Expenditure | -322 | -108 | -313 | -291 | -253 |
| Free Cash Flow | -17,601 | -9,792 | -79,221 | -65,464 | -49,761 |